Atlas Trials

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.

Clinical trial NCT06253117 · RECRUITING

Trial details

NCT number
NCT06253117
Sponsor
University of Alabama at Birmingham
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Acute Pancreatitis
Start date
2024-06-27
Primary completion
2028-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.